181 related articles for article (PubMed ID: 34743162)
1. Temporomandibular Disorder Patients Benefit From Intramuscular Botulinum Toxin Type a Injections.
Oksanen E; Männistö V; Kormi E; Vallioniemi H; Suojanen J
J Craniofac Surg; 2022 Jun; 33(4):1159-1161. PubMed ID: 34743162
[TBL] [Abstract][Full Text] [Related]
2. Occlusal force characteristics of masseteric muscles after intramuscular injection of botulinum toxin A(BTX - A)for treatment of temporomandibular disorder.
Zhang LD; Liu Q; Zou DR; Yu LF
Br J Oral Maxillofac Surg; 2016 Sep; 54(7):736-40. PubMed ID: 27138229
[TBL] [Abstract][Full Text] [Related]
3. Assessing change in functional outcomes and quality of life in myogenic temporomandibular disorders undergoing botulinum toxin injection: A before and after comparison.
Hosgor H; Coskunses FM; Altindis S
J Stomatol Oral Maxillofac Surg; 2023 Sep; 124(4):101434. PubMed ID: 36914004
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular botulinum toxin injection additional to arthrocentesis in the management of temporomandibular joint pain.
Ivask O; Leibur E; Akermann S; Tamme T; Voog-Oras Ü
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):e99-e106. PubMed ID: 27496577
[TBL] [Abstract][Full Text] [Related]
5. Effect of multiple injections of botulinum toxin into painful masticatory muscles on bone density in the temporomandibular complex.
Raphael KG; Janal MN; Tadinada A; Santiago V; Sirois DA; Lurie AG
J Oral Rehabil; 2020 Nov; 47(11):1319-1329. PubMed ID: 32885475
[TBL] [Abstract][Full Text] [Related]
6. Does Adjunctive Botulinum Toxin A Reduce Pain Scores When Combined With Temporomandibular Joint Arthroscopy for the Treatment of Concomitant Temporomandibular Joint Arthralgia and Myofascial Pain?
Thomas NJ; Aronovich S
J Oral Maxillofac Surg; 2017 Dec; 75(12):2521-2528. PubMed ID: 28500876
[TBL] [Abstract][Full Text] [Related]
7. Improvement in quality of life after botulinum toxin injection for temporomandibular disorder.
Villa S; Raoul G; Machuron F; Ferri J; Nicot R
J Stomatol Oral Maxillofac Surg; 2019 Feb; 120(1):2-6. PubMed ID: 30385428
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy of occlusal splint and botulinum toxin therapies in patients with temporomandibular disorders with sleep bruxism.
Hosgor H; Altindis S; Sen E
J Orofac Orthop; 2024 May; 85(Suppl 1):102-108. PubMed ID: 37843582
[TBL] [Abstract][Full Text] [Related]
9. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.
Pihut M; Ferendiuk E; Szewczyk M; Kasprzyk K; Wieckiewicz M
J Headache Pain; 2016; 17():29. PubMed ID: 27011213
[TBL] [Abstract][Full Text] [Related]
10. The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings.
Freund B; Schwartz M; Symington JM
J Oral Maxillofac Surg; 1999 Aug; 57(8):916-20; discussion 920-1. PubMed ID: 10437718
[TBL] [Abstract][Full Text] [Related]
11. Botulinum Toxin for Treating Temporomandibular Disorders: What is the Evidence?
Delcanho R; Val M; Guarda Nardini L; Manfredini D
J Oral Facial Pain Headache; 2022; 36(1):6-20. PubMed ID: 35298571
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of botulinum toxin therapy in treatment of myofascial pain.
Chaurand J; Pacheco-Ruíz L; Orozco-Saldívar H; López-Valdés J
J Oral Sci; 2017; 59(3):351-356. PubMed ID: 28904310
[TBL] [Abstract][Full Text] [Related]
13. The effects of botulinum toxin A injection on the lateral pterygoid muscle in patients with a painful temporomandibular joint click: a randomized clinical trial study.
Rezazadeh F; Esnaashari N; Azad A; Emad S
BMC Oral Health; 2022 May; 22(1):217. PubMed ID: 35641993
[TBL] [Abstract][Full Text] [Related]
14. Effect of botulinum toxin type A on muscular temporomandibular disorder: A systematic review and meta-analysis of randomized controlled trials.
Li K; Tan K; Yacovelli A; Bi WG
J Oral Rehabil; 2024 May; 51(5):886-897. PubMed ID: 38151884
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin in the management of myalgia in temporomandibular disorders: are all injections equal?
Anwar H; Attard A; Green J; Elledge ROC
Br J Oral Maxillofac Surg; 2023 Jan; 61(1):89-93. PubMed ID: 36522255
[TBL] [Abstract][Full Text] [Related]
16. Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections.
Abboud WA; Hassin-Baer S; Joachim M; Givol N; Yahalom R
Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1417-1423. PubMed ID: 28521968
[TBL] [Abstract][Full Text] [Related]
17. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
Lang AM
Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
[TBL] [Abstract][Full Text] [Related]
18. Unclear results for the use of botulinum toxin therapy for TMD pain.
Keenan JR
Evid Based Dent; 2015 Dec; 16(4):122. PubMed ID: 26680526
[TBL] [Abstract][Full Text] [Related]
19. Effects of masticatory muscle function affected by BTX on maxillofacial bone growth through the sutural modification.
Tsai CY; Wang CW; Chang CW
Orthod Craniofac Res; 2019 May; 22(2):112-117. PubMed ID: 30657256
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of articular disc loading in the temporomandibular joints after prosthetic and pharmacological treatment in model studies.
Pihut ME; Margielewicz J; Kijak E; Wiśniewska G
Adv Clin Exp Med; 2017; 26(3):455-460. PubMed ID: 28791820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
